These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The treatment of patients having spontaneously occurring antibodies to antihaemophilic factor (factor VIII). Rizza CR; Edgcumbe JO; Pitney WR; Child JA Thromb Diath Haemorrh; 1972 Aug; 28(1):120-8. PubMed ID: 5074988 [No Abstract] [Full Text] [Related]
4. [Coagulopathy with autoantibodies to blood-clotting factors: overview and laboratory diagnosis]. Arai M Rinsho Byori; 2004 Feb; 52(2):178-81. PubMed ID: 15027324 [TBL] [Abstract][Full Text] [Related]
5. An idiopathic factor VIII anticoagulant: resolution following plasmapheresis and cytotoxic therapy. Goldsmith JC; Hamilton HE Am J Med Sci; 1985 Dec; 290(6):246-8. PubMed ID: 3936359 [TBL] [Abstract][Full Text] [Related]
6. Hemofil and other factor VIII concentrates. Med Lett Drugs Ther; 1969 Nov; 11(23):96. PubMed ID: 5375104 [No Abstract] [Full Text] [Related]
7. [Immunocoagulopathies as a possible cause of acquired hemorrhagic diathesis]. Klare M; Möller T; Hanke P; Weller P; Seige K Z Gesamte Inn Med; 1983 May; 38(10):277-80. PubMed ID: 6412468 [TBL] [Abstract][Full Text] [Related]
9. Continuous infusion of porcine factor VIII for the treatment of patients with factor VIII inhibitors. Bona RD; Riberio M; Klatsky AU; Panek S; Magnifico M; Rickles FR Semin Hematol; 1993 Apr; 30(2 Suppl 1):32-5. PubMed ID: 8480196 [No Abstract] [Full Text] [Related]
10. Circulating anticoagulant due to Factor 8 deficiency with spontaneous remission: case report. Getzen JH South Med J; 1967 Apr; 60(4):378-81. PubMed ID: 6021533 [No Abstract] [Full Text] [Related]
11. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors. Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895 [TBL] [Abstract][Full Text] [Related]
13. Treatment of a case of factor VIII inhibitor in an elderly female. Denham MJ; Sneath P; Walford DM Gerontol Clin (Basel); 1973; 15(1):10-4. PubMed ID: 4796450 [No Abstract] [Full Text] [Related]
15. Use of blood products and factor concentrates for coagulation therapy. Fritsma MG Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192 [TBL] [Abstract][Full Text] [Related]
16. Acquired factor VIII inhibitor associated with prostatic cancer: successful treatment with steroid and immunosuppressive therapy. Moccia F; Tognoni E; Boccaccio P Ann Ital Med Int; 2000; 15(2):172-6. PubMed ID: 10920509 [TBL] [Abstract][Full Text] [Related]
17. Circulating anticoagulant against factor XI in psoriasis. Rustgi RN; LaDuca FM; Tourbaf KD J Med; 1982; 13(4):289-301. PubMed ID: 6957528 [TBL] [Abstract][Full Text] [Related]
18. [Blood plasma fractions for the treatment of coagulation disorders. II. Production and clinical use of factor VIII containing preparations]. Richter K Z Gesamte Inn Med; 1967 Aug; 22(15):451-6. PubMed ID: 5592694 [No Abstract] [Full Text] [Related]
19. Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant. Green D; Hougie C; Kazmier FJ; Lechner K; Mannucci PM; Rizza CR; Sultan Y Thromb Haemost; 1983 Apr; 49(2):144-6. PubMed ID: 6408752 [No Abstract] [Full Text] [Related]
20. [Directions for blood component therapy in blood coagulation disorders]. Rasche H Klin Anasthesiol Intensivther; 1980; 21():136-51. PubMed ID: 6779052 [No Abstract] [Full Text] [Related] [Next] [New Search]